What are look-alike/sound-alike LASA drugs, and what strategies reduce LASA errors?

• A. LASA drugs are drugs with similar names or appearances that cause confusion; strategies include tall-man lettering, distinct packaging, barcode verification, and education.
• B. LASA stands for Look-At-Sound-Alike, a concept not related to names.
• C. LASA refers to any drug with identical color packaging.
• D. LASA errors occur only in community pharmacies.

Answer: (A)

Look-alike/sound-alike drugs are medications whose names look or sound similar, and sometimes their appearance or labeling is also alike. This similarity can lead to confusion during prescribing, dispensing, or administration and raise the risk of giving the wrong drug, wrong dose, or wrong route. The best choice captures both the definition and practical safeguards: it identifies LASA as name-related and appearance-related confusion and lists effective strategies to reduce those errors.

Strategies like tall-man lettering highlight the differences within similar names, helping clinicians notice the distinction at a glance. Distinct packaging and labeling further minimize visual mix-ups by making each product visually unique. Barcode verification provides a concrete, automated check that the scanned product matches what was prescribed and intended for the patient, catching mistakes before administration. Education ensures that staff remain aware of LASA risks and know how to apply these safeguards consistently. Together, these steps strengthen safety across prescribing, dispensing, and administration, rather than relying on a single precaution.

These measures align with how LASA risks arise and how they’re mitigated. The concept is about look-alike and sound-alike names (not a different acronym), and LASA concerns extend beyond a single setting like community pharmacies, encompassing multiple points in the medication-use process.